Michael Kolodziej, MD, and Louis Jacques, MD, discuss the implications of the proposed NCD on Next-Generation Sequencing for oncologists

The proposed NCD has generated a lot of discussion in the medical community. While this offers the potential to move things forward in precision medicine, there are several questions that remain to be answered. The Community Oncology Alliance, in collaboration with ADVI, a Washington, DC, consultancy that specializes in healthcare payment strategies, recently held a webinar discussion of the specifications and implications of the proposal, in advance of the end of the public comment period on the NCD.